APTO - XP AMC Entertainment Doximity among premarket losers' pack

December, 14 2021 08:30 AM Aptose Biosciences Inc.

Adagio Therapeutics (NASDAQ:ADGI) -67% after Omicron led to 300-fold reduction in neutralizing effect in COVID-19 therapy. Aptose Biosciences (NASDAQ:APTO) -32% following ASH data on acute myeloid leukemia candidate. SeaChange International (NASDAQ:SEAC) -22%. Mesoblast (NASDAQ:MESO) -18% after Novartis terminates deal prior to closing. Planet Labs (NYSE:PL) -15% on Q3 earnings release. Oscar Health (NYSE:OSCR) -11%. Global Blood Therapeutics (NASDAQ:GBT) -10% after announcing offering of $250.0M in convertible senior notes. Energy Focus (NASDAQ:EFOI) -10%. Dingdong (Cayman) (NYSE:DDL) -10%. American Virtual Cloud Technologies (NASDAQ:AVCT) -9%. Petros Pharmaceuticals (NASDAQ:PTPI) -8%. Cidara Therapeutics (NASDAQ:CDTX) -7% despite 'positive' Phase 3 rezafungin data in candidemia/invasive candidiasis. Midatech Pharma (NASDAQ:MTP) -7%. Foghorn Therapeutics (NASDAQ:FHTX) -7%. IAMGOLD (NYSE:IAG) -7%. Doximity (NYSE:DOCS) -6%. Sasol (NYSE:SSL) -6% update on Sasol Secunda'S operational performance. AMC Entertainment Holdings (NYSE:AMC) -6% #AMC500K trends on Twitter as meme stocks keep sliding. Reliance Global Group (NASDAQ:RELI) -6%. XP (NASDAQ:XP) -5%. Inspira Technologies Oxy (NASDAQ:IINN) -5%.

For further details see:

XP, AMC Entertainment, Doximity among premarket losers' pack

Company Name:	Aptose Biosciences Inc.
Stock Symbol:	APTO
Market:	NASDAQ
Website:	aptose.com